Usca Ria LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 352 shares of the medical equipment provider’s stock, valued at approximately $202,000.
A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 54.3% during the second quarter. Fisher Asset Management LLC now owns 907 shares of the medical equipment provider’s stock worth $434,000 after acquiring an additional 319 shares during the last quarter. Trust Co. of Vermont raised its stake in shares of Intuitive Surgical by 11.6% in the second quarter. Trust Co. of Vermont now owns 1,543 shares of the medical equipment provider’s stock valued at $738,000 after acquiring an additional 160 shares during the period. Xact Kapitalforvaltning AB raised its stake in shares of Intuitive Surgical by 2.8% in the second quarter. Xact Kapitalforvaltning AB now owns 22,461 shares of the medical equipment provider’s stock valued at $10,747,000 after acquiring an additional 604 shares during the period. Raymond James Trust N.A. purchased a new stake in shares of Intuitive Surgical in the second quarter valued at $213,000. Finally, First Citizens Bank & Trust Co. increased its stake in Intuitive Surgical by 11.4% in the 2nd quarter. First Citizens Bank & Trust Co. now owns 1,923 shares of the medical equipment provider’s stock worth $920,000 after buying an additional 197 shares during the period. 84.16% of the stock is currently owned by institutional investors.
In other Intuitive Surgical news, Director Mark J. Rubash sold 150 shares of the stock in a transaction on Monday, August 27th. The stock was sold at an average price of $543.66, for a total value of $81,549.00. Following the completion of the transaction, the director now owns 4,116 shares in the company, valued at $2,237,704.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Salvatore Brogna sold 2,652 shares of the stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $557.39, for a total value of $1,478,198.28. Following the completion of the transaction, the chief operating officer now owns 2,049 shares of the company’s stock, valued at approximately $1,142,092.11. The disclosure for this sale can be found here. Insiders have sold 47,311 shares of company stock valued at $24,144,846 in the last 90 days. Company insiders own 2.20% of the company’s stock.
ISRG has been the topic of several recent research reports. Piper Jaffray Companies upgraded shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 target price on the stock in a report on Tuesday, October 9th. Wells Fargo & Co raised their price target on shares of Intuitive Surgical from $575.00 to $635.00 and gave the company an “outperform” rating in a report on Wednesday, September 12th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 price objective for the company in a research report on Tuesday, July 24th. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 31st. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $620.00 price target (up from $510.00) on shares of Intuitive Surgical in a research report on Friday, July 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have given a buy rating to the company’s stock. Intuitive Surgical currently has an average rating of “Buy” and a consensus target price of $554.64.
Shares of Intuitive Surgical stock opened at $532.56 on Friday. Intuitive Surgical, Inc. has a one year low of $359.75 and a one year high of $581.12. The stock has a market cap of $62.32 billion, a PE ratio of 74.07, a P/E/G ratio of 3.66 and a beta of 1.02.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.66 by $0.17. The firm had revenue of $920.90 million during the quarter, compared to the consensus estimate of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.77 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 9.52 EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/11/10/usca-ria-llc-takes-position-in-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Story: Outstanding Shares, Buying and Selling Stocks
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.